Zydus Lifesciences Limited Financial Overview
Zydus Lifesciences Limited's market cap is currently ₹978.91B. The company's EPS TTM is ₹12.3; its P/E ratio is 21.41; and it has a dividend yield of 1.18%. Zydus Lifesciences Limited is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹7.90. See an overview of income statement, balance sheet, and cash flow financials.
